MAA
FOLD

Managed Account Advisors’s Amicus Therapeutics FOLD Stock Holding History

Managed Account Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$93K Sell
6,602
-2,501
-27% -$30.1K ﹤0.01% 2605
2015
Q1 		$99K Buy
+9,103
New +$80.2K ﹤0.01% 2542

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Managed Account Advisors's FOLD Position: Q2 2015 in Review

Managed Account Advisors reduced its Amicus Therapeutics (FOLD) stake by 27% in Q2 2015, selling an estimated $30.1K and leaving 6,602 shares worth $93K. The position accounts for ﹤0.01% of the portfolio, ranked #2605.

Managed Account Advisors first reported a position in FOLD in Q1 2015 and has held it in 2 quarters since. The position peaked at $99K in Q1 2015. 140 funds tracked by Wall St. Rank hold FOLD as of Q2 2015.

  • Managed Account Advisors held 6,602 shares of Amicus Therapeutics worth $93K as of Q2 2015.
  • Managed Account Advisors sold 2,501 Amicus Therapeutics shares in Q2 2015, an estimated $30.1K.
  • Amicus Therapeutics made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2605 holding.
  • Managed Account Advisors first reported a position in Amicus Therapeutics in Q1 2015 and has held it in 2 quarters since.
  • Managed Account Advisors's Amicus Therapeutics position peaked at $99K in Q1 2015.
  • 140 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.